NAZEM FARZAD 4
4 · Nautilus Biotechnology, Inc. · Filed Jun 16, 2022
Insider Transaction Report
Form 4
NAZEM FARZAD
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-15+86,467→ 86,467 totalExercise: $2.70Exp: 2032-06-15→ Common Stock (86,467 underlying)
Footnotes (1)
- [F1]Subject to reporting person's continuous status as a "Service Provider" (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month).